Finance

Lists
IBAB:EBR
Ion Beam Applications SA
€ 16.20
+1.63%
(+0.26) 1D
10-р сарын 14, 17:35:06 (GMT+2)  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for IBAB...
Open
€ 16.00
High
€ 16.32
Low
€ 15.90
Mkt. cap
490.57 сая
Avg. vol.
15.47 мян
Volume
13.55 мян
Dividend
1.08%
Quarterly dividend
€ 0.04
Ex-dividend date
2026 оны 6-р сарын 15
P/E ratio
20.35
52-wk high
€ 17.76
52-wk low
€ 9.90
EPS
€ 0.80
Shares outstanding
30.28 сая
No. of employees
2 мян
Open
€ 16.00
High
€ 16.32
Low
€ 15.90
Mkt. cap
490.57 сая
Avg. vol.
15.47 мян
Volume
13.55 мян
Dividend
1.08%
Quarterly dividend
€ 0.04
Ex-dividend date
2026 оны 6-р сарын 15
P/E ratio
20.35
52-wk high
€ 17.76
52-wk low
€ 9.90
EPS
€ 0.80
Shares outstanding
30.28 сая
No. of employees
2 мян
News stories
From web sources and news partners
Profile
IBA is a medical technology company based in Louvain-la-Neuve. The company was founded in 1986 by Yves Jongen within the Cyclotron Research Center of the University of Louvain and became a university spin-off. It employs about 1500 people in 40 locations. The company developed cyclotrons and integrated proton therapy centers is active in the field of proton therapy, dosimetry, radiopharmacy solutions and industrial sterilisation. IBA installed its first proton therapy equipment for Boston's Massachusetts General Hospital in 2001, and for University of Pennsylvania's Proton Center in 2009. It supplied equipment and services to Proton Partners International which was developing three proton beam therapy centers in the United Kingdom. In 2017, IBA invested €16 million in the construction of a new logistics and production center in Louvain-la-Neuve. Wikipedia
About Ion Beam Applications SA
CEOOlivier Legrain
Employees2.26 мян
Founded1986
Headquarters-
Sector-
Previous reportsAll values in EUR
Loading Previous Earnings...
Revenue
Net income
All values in EUR
2025 оны 9-р сар
2025 оны 12-р сар
2026 оны 3-р сар
2026 оны 6-р сар
Revenue
157.64 сая
157.64 сая
161.87 сая
161.87 сая
Cost of goods sold
102.83 сая
102.83 сая
107.40 сая
107.40 сая
Cost of revenue
102.83 сая
102.83 сая
107.40 сая
107.40 сая
Research and development expenses
15.48 сая
15.48 сая
18.20 сая
18.20 сая
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
30.94 сая
30.94 сая
28.22 сая
28.22 сая
Operating expense
40.94 сая
40.94 сая
48.03 сая
48.03 сая
Total operating expenses
143.77 сая
143.77 сая
155.43 сая
155.43 сая
Operating income
13.86 сая
13.86 сая
6.45 сая
6.45 сая
Other non operating income
-1.29 сая
-1.29 сая
-
-
EBT including unusual items
8.78 сая
8.78 сая
6.14 сая
6.14 сая
EBT excluding unusual items
13.05 сая
13.05 сая
6.20 сая
6.20 сая
Income tax expense
1.12 сая
1.12 сая
1.48 сая
1.48 сая
Effective tax rate
12.73%
12.73%
24.10%
24.10%
Other operating expenses
-5.83 сая
-5.83 сая
1.60 сая
1.60 сая
Net income
7.67 сая
7.67 сая
4.66 сая
4.66 сая
Net profit margin
4.86%
4.86%
2.88%
2.88%
Earnings per share
-
-
-
-
Interest and investment income
2.13 сая
2.13 сая
1.88 сая
1.88 сая
Interest expense
-
-
-3.18 сая
-3.18 сая
Net interest expenses
2.13 сая
2.13 сая
-1.31 сая
-1.31 сая
Depreciation and amortization charges
-
-
-
-
EBITDA
15.80 сая
15.17 сая
8.41 сая
8.41 сая
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google аппс